In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by ...
October is National Substance Abuse Prevention Month, an opportunity to recognize the impact of substance use in the U.S. and ...
In a bold step towards tackling the HIV epidemic, the Ministry of Health and Wellness is now considering a pilot programme ...
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...
MedPage Today on MSN
CDC Backs Twice-Yearly Injectable for HIV Prevention
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...
The Print on MSN
HIV prevention jab in India soon at fraction of US cost? 2 drugmakers set to roll out generics
Year's supply of injectable to cost Rs 3,549, compared to over Rs 17 lakh in US. Powerful alternative to daily oral PrEP, ...
Global health groups will provide backing for two generic manufacturers to produce and distribute a low-cost version of a new ...
The Food and Drug Administration has approved Yeztugo, a revolutionary HIV prevention injection that represents the most significant advancement in HIV prevention strategies in more than four decades.
Opinion
Mitigating the global impact of changing HIV policies in the US: a call for advocacy and action
Key points On Jan. 20, 2025, the incoming United States administration froze all foreign assistance funds for 90 days, including the President’s Emergency Plan for AIDS Relief (PEPFAR) funding.[1][1] ...
Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback